StonvexLoading…
StonvexStonvexStonvexCore line items from SPFI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $252.00M | $240.90M | $212.03M | $161.17M |
Operating Income | $74.07M | $63.29M | $79.42M | $73.15M |
Net Income | $58.47M | $49.72M | $62.74M | $58.24M |
EPS (Diluted) | $3.44 | $2.92 | $3.62 | $3.23 |
Total Assets | $4.48B | $4.23B | $4.20B | $3.94B |
Total Liabilities | $3.99B | $3.79B | $3.80B | $3.59B |
Cash & Equivalents | $552.44M | $359.08M | $330.16M | $234.88M |
Free Cash Flow OCF − CapEx | $71.83M | $56.03M | $53.86M | $119.12M |
Shares Outstanding | 16.29M | 16.46M | 17.33M | 18.02M |